메뉴 건너뛰기




Volumn 11, Issue 1, 2017, Pages 3-25

3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 1: Diagnosis and medical management

(43)  Gomollón, Fernando a   Dignass, Axel b   Annese, Vito c   Tilg, Herbert d   Van Assche, Gert e   Lindsay, James O f   Peyrin Biroulet, Laurent g   Cullen, Garret J h   Daperno, Marco i   Kucharzik, Torsten j   Rieder, Florian k   Almer, Sven l   Armuzzi, Alessandro m   Harbord, Marcus n,v   Langhorst, Jost o   Sans, Miquel p   Chowers, Yehuda q   Fiorino, Gionata r   Juillerat, Pascal s   Mantzaris, Gerassimos J t   more..


Author keywords

Biologics; Crohn's disease; Fistulizing disease; Immunosuppressant; Perianal disease; Steroids; Strictureplasty; Thiopurine; Treatment; Vedolizumab

Indexed keywords

ADALIMUMAB; ANTIBIOTIC AGENT; AZATHIOPRINE; BIOLOGICAL PRODUCT; BUDESONIDE; CERTOLIZUMAB PEGOL; CORTICOSTEROID; CYCLOSPORIN; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MESALAZINE; METHOTREXATE; MYCOPHENOLATE MOFETIL; NATALIZUMAB; OMEGA 3 FATTY ACID; PREDNISOLONE; PROBIOTIC AGENT; STEROID; TACROLIMUS; TUMOR NECROSIS FACTOR ANTIBODY; VEDOLIZUMAB;

EID: 85016186433     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jjw168     Document Type: Article
Times cited : (1575)

References (1)
  • 1
    • 85019692204 scopus 로고    scopus 로고
    • References for this paper are available as supplementary data at ECCO-JCC online
    • References for this paper are available as supplementary data at ECCO-JCC online


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.